Converging pathways in neurodegeneration, from genetics to mechanisms
- PMID: 30258237
- PMCID: PMC6278826
- DOI: 10.1038/s41593-018-0237-7
Converging pathways in neurodegeneration, from genetics to mechanisms
Abstract
Neurodegenerative diseases cause progressive loss of cognitive and/or motor function and pose major challenges for societies with rapidly aging populations. Human genetics studies have shown that disease-causing rare mutations and risk-associated common alleles overlap in different neurodegenerative disorders. Here we review the intricate genotype-phenotype relationships and common cellular pathways emerging from recent genetic and mechanistic studies. Shared pathological mechanisms include defective protein quality-control and degradation pathways, dysfunctional mitochondrial homeostasis, stress granules, and maladaptive innate immune responses. Research efforts have started to bear fruit, as shown by recent treatment successes and an encouraging therapeutic outlook.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures
References
-
- Prince M et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63–75.e2 (2013). - PubMed
-
- Taylor JP, Hardy J & Fischbeck KH Toxic proteins in neurodegenerative disease. Science 296, 1991–1995 (2002). - PubMed
-
- Goedert M, Eisenberg DS & Crowther RA Propagation of tau aggregates and neurodegeneration. Annu. Rev. Neurosci 40, 189–210 (2017). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
